Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0999 USD | +99.80% | +99.80% | -13.13% |
2023 | Earnings Flash (FZMD) FUSE MEDIAL Reports Q2 Revenue $5M | MT |
2023 | Fuse Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
Financials (USD)
Sales 2021 | 20.41M | Sales 2022 | 18.64M | Capitalization | 10.55M |
---|---|---|---|---|---|
Net income 2021 | -1M | Net income 2022 | 3M | EV / Sales 2021 | 1.59 x |
Net Debt 2021 | 2.23M | Net Debt 2022 | 2.2M | EV / Sales 2022 | 0.68 x |
P/E ratio 2021 |
-19
x | P/E ratio 2022 |
3.75
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 13.11% |
1 day | +99.80% | ||
1 week | +99.80% | ||
Current month | +99.80% | ||
1 month | +21.68% | ||
3 months | -7.07% | ||
6 months | -13.13% | ||
Current year | -13.13% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Reeg
CEO | Chief Executive Officer | 60 | 16-12-18 |
Mark Brooks
CHM | Chairman | 58 | 16-12-18 |
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Yellin
DFI | Director of Finance/CFO | 66 | 22-04-03 |
Christopher Reeg
CEO | Chief Executive Officer | 60 | 16-12-18 |
Mark Brooks
CHM | Chairman | 58 | 16-12-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-01 | 0.0999 | +99.80% | 500 |
Delayed Quote OTC Markets, July 01, 2024 at 01:56 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-13.13% | 7.03M | |
-7.03% | 178B | |
-6.32% | 98.95B | |
-6.15% | 66.14B | |
-10.62% | 44.11B | |
+8.34% | 43.82B | |
+11.91% | 42.07B | |
+11.64% | 28.92B | |
+17.68% | 24.69B | |
-8.87% | 23.38B |
- Stock Market
- Equities
- FZMD Stock